Insitro, Inc.
- Biotech or pharma, therapeutic R&D
AI/ML biology discovery company leveraging multi-modal human and multi-modal cellular data at scale to uncover novel genetic intervention points in disease and advance a wholly owned and partnered pipeline in metabolic disease (MASLD, obesity) and neuroscience.